Search research articles
Contact Us
Filters
Showing results (201-210 of 511) with videos related to
Page
of 52
Sort By:
Neurology
|
January 2, 2024
Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset
Jan Kern, Judith Böhringer, Dagmar Timmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 21, 2024
FARS-ADL across Ataxias: Construct Validity, Sensitivity to Change, and Minimal Important Change
Andreas Traschütz, Zofia Fleszar, Holger Hengel, et al.
Acta Neuropathologica
|
November 28, 2025
A new FTLD-TDP subtype with annexin A11 co-pathology
Manuela Neumann, Marleen Van den Broeck, Sarah Wynants, et al.
Brain : a Journal of Neurology
|
April 26, 2022
The prodromal phase of hereditary spastic paraplegia type 4: the preSPG4 cohort study
Tim W Rattay, Maximilian Völker, Maren Rautenberg, et al.
Frontiers in Neurology
|
July 6, 2019
Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's Disease
Eva Schaeffer, Jan-Hinrich Busch, Benjamin Roeben, et al.
American Journal of Human Genetics
|
May 26, 2026
Guidance on communication and informed consent with patients and their families for experimental individualized treatments
Annemieke Aartsma-Rus, Claudio M de Gusmao, Scott Demarest, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 5, 2025
A Pharmacometrics-Informed Trial Simulation Framework for Optimizing Study Designs for Disease-Modifying Treatments in Rare Neurological Disorders
Yevgen Ryeznik, Ralf-Dieter Hilgers, Nicole Heussen, et al.
European Journal of Neurology
|
November 1, 2021
Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's disease
Eva Schaeffer, Benjamin Roeben, Oliver Granert, et al.
Parkinsonism & Related Disorders
|
December 8, 2018
The movement disorder spectrum of SCA21 (ATX-TMEM240): 3 novel families and systematic review of the literature
Andreas Traschütz, Judith van Gaalen, Mayke Oosterloo, et al.
Brain : a Journal of Neurology
|
November 22, 2012
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway
Kinnari Sathe, Walter Maetzler, Johannes D Lang, et al.
Page
of 52
Search research articles
Search
Showing results (201-210 of 511) with videos related to
Sort By:
Page
of 52
Neurology
|
January 2, 2024
Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset
Jan Kern, Judith Böhringer, Dagmar Timmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 21, 2024
FARS-ADL across Ataxias: Construct Validity, Sensitivity to Change, and Minimal Important Change
Andreas Traschütz, Zofia Fleszar, Holger Hengel, et al.
Acta Neuropathologica
|
November 28, 2025
A new FTLD-TDP subtype with annexin A11 co-pathology
Manuela Neumann, Marleen Van den Broeck, Sarah Wynants, et al.
Brain : a Journal of Neurology
|
April 26, 2022
The prodromal phase of hereditary spastic paraplegia type 4: the preSPG4 cohort study
Tim W Rattay, Maximilian Völker, Maren Rautenberg, et al.
Frontiers in Neurology
|
July 6, 2019
Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's Disease
Eva Schaeffer, Jan-Hinrich Busch, Benjamin Roeben, et al.
American Journal of Human Genetics
|
May 26, 2026
Guidance on communication and informed consent with patients and their families for experimental individualized treatments
Annemieke Aartsma-Rus, Claudio M de Gusmao, Scott Demarest, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 5, 2025
A Pharmacometrics-Informed Trial Simulation Framework for Optimizing Study Designs for Disease-Modifying Treatments in Rare Neurological Disorders
Yevgen Ryeznik, Ralf-Dieter Hilgers, Nicole Heussen, et al.
European Journal of Neurology
|
November 1, 2021
Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's disease
Eva Schaeffer, Benjamin Roeben, Oliver Granert, et al.
Parkinsonism & Related Disorders
|
December 8, 2018
The movement disorder spectrum of SCA21 (ATX-TMEM240): 3 novel families and systematic review of the literature
Andreas Traschütz, Judith van Gaalen, Mayke Oosterloo, et al.
Brain : a Journal of Neurology
|
November 22, 2012
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway
Kinnari Sathe, Walter Maetzler, Johannes D Lang, et al.
Page
of 52